Lymphotactin as an adjuvant

Details Lymphotactin as an adjuvant Lymphotactin as an adjuvant

A - Human Necessities

61

K

A61K 38/19 (2006.01) A61K 39/39 (2006.01) C07K 14/52 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2316323

A method of enhancing immune response by administration of an immune-enhancing effective amount of lymphotactin in a pharmaceutically acceptable carrier.

La présente invention concerne un procédé permettant de stimuler la réponse immunitaire en administrant dans un vecteur pharmaceutiquement acceptable une quantité efficace de lymphotactine pour stimuler la réponse immunitaire.

Affiliated with

Also associated with

Rating

Lymphotactin as an adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lymphotactin as an adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lymphotactin as an adjuvant will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2031452